Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

38.15
Delayed Data
As of 4:02pm ET
 +0.11 / +0.29%
Today’s Change
37.41
Today|||52-Week Range
51.88
-10.55%
Year-to-Date
3 Critical FDA Decisions You Can't Afford to Miss
5:47pm / MotleyFool.com - Paid Partner Content
Wells Fargo One of Only Two Buffett Stocks at 52-Week Low Price After Scandal
Sep 21 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alp...
10:19am / Zacks.com - Paid Partner Content
Sanofi Sues Merck Over Patent Infringement
Sep 20 / GuruFocus News - Paid Partner Content
Biosimilars in Limelight on FDA Approval of Amgen Drug
9:04am / Zacks.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
Regeneron, Sanofi Skin Disease Drug Under Priority Review
Sep 26 / Zacks.com - Paid Partner Content
This Diabetes Breakthrough Is Great News or Terrible News, Depending on Your Perspect...
Sep 19 / MotleyFool.com - Paid Partner Content
The Internet of Medical Things: 6 Stocks in Focus
Sep 26 / Zacks.com - Paid Partner Content
6 Flu Season Facts You Probably Don't Know
Sep 17 / MotleyFool.com - Paid Partner Content
Better Buy: Ziopharm Oncology, Inc. vs. Alnylam Pharmaceuticals, Inc.
Sep 24 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data
Sep 16 / Zacks.com - Paid Partner Content
John Paulson Trims Synergy
Sep 23 / GuruFocus News - Paid Partner Content
Sanofi (SNY) Presents Positive Diabetes Data on iGlarLixi (revised)
Sep 15 / Zacks.com - Paid Partner Content
European Markets Rally Following Fed Decision; Oil Price Increase
Sep 22 / TheStreet.com - Paid Partner Content
Sanofi (SNY) Presents Positive Diabetes Data on iGlarLixi
Sep 14 / Zacks.com - Paid Partner Content
Buffett Stock Wells Fargo Falls Close to 52-Week Low Post Scandal
Sep 22 / GuruFocus News - Paid Partner Content
Is This Lexicon Pharmaceuticals' Year?
Sep 13 / MotleyFool.com - Paid Partner Content
New Setback for Sanofi's Lantus Increases Need for M&A
Sep 22 / TheStreet.com - Paid Partner Content
Biotech Stocks Bounce Back in Monday Trading: 3 Picks
Sep 13 / Zacks.com - Paid Partner Content
Buffett Stock Wells Fargo Falls to 52-Week Low After Scandal
Sep 22 / GuruFocus News - Paid Partner Content